Literature DB >> 9507161

Immunocytochemical localization of an imidazoline receptor protein in the central nervous system.

D A Ruggiero1, S Regunathan, H Wang, T A Milner, D J Reis.   

Abstract

Imidazoline (I) receptors have been implicated in the regulation of arterial blood pressure and behavior although their distribution in the central nervous system (CNS) remains in question. Presumptive I- receptor sites were detected in the rat central nervous system with a polyclonal antibody to an imidazoline receptor protein (IRP) with binding characteristics of the native receptor. IRP-like immunoreactivity (LI) was detected in neurons and glia by light and electron microscopy. Spinal cord: processes were heavily labeled in superficial laminae I and II of the dorsal horn, lateral-cervical and -spinal nuclei and sympathetic cell column. Medulla: label was concentrated in the area postrema, rostral, subpostremal and central subnuclei of nucleus tractus solitarii, spinal trigeminal nucleus caudalis, and inferior olivary subnuclei. Visceromotor neurons in the dorsal vagal and ambigual nuclei were surrounded by high concentrations of immunoreactive processes. In reticular formation, label was light, though predominant in the intermediate reticular zone and ventrolateral medulla. Pons: label was detected in the neuropil of the periventricular gray, concentrated in the dorsal- and external-lateral subnuclei of lateral parabrachial nucleus, and present intracellularly in the mesencephalic trigeminal nucleus. Midbrain: IRP-LI was most heavily concentrated in the interpeduncular nucleus, nuclei interfascicularis and rostral-linearis, the subcommissural organ, central gray, and in glia surrounding the cerebral aqueduct. Diencephalon: high densities were detected in the medial habenular nucleus, nucleus paraventricularis thalami, other midline-intralaminar thalamic nuclei, the supramammillary and mediobasal hypothalamic nuclei. In the median eminence, immunolabeled processes were restricted to the lamina interna and lateral subependymal zone. Telencephalon: IRP-LI was concentrated in the central amygdaloid nucleus, bed nucleus of stria terminalis and globus pallidus, followed by moderate labeling of the medial amygdaloid nucleus, amygdalostriatal zone and caudoputamen, the hilus of the dentate gyrus, and stratum lacunosum-moleculare of field CA1 of Ammon's horn. The subfornical organ and organum vasculosum lamina terminalis were filled with diffuse granular immunoreactivity. Ultrastructural studies identified IRP-LI within glia and neurons including presynaptic processes. I-receptor(s) localize to a highly restricted network of neurons in the CNS and circumventricular regions lying outside of the blood-brain barrier. Putative imidazoline receptors have a unique distribution pattern, show partial overlap with alpha 2 adrenoreceptors and are heavily represented in sensory processing centers and the visceral nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507161     DOI: 10.1016/s0006-8993(97)01203-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice.

Authors:  Christian Griñán-Ferré; Foteini Vasilopoulou; Sònia Abás; Sergio Rodríguez-Arévalo; Andrea Bagán; Francesc X Sureda; Belén Pérez; Luis F Callado; Jesús A García-Sevilla; M Julia García-Fuster; Carmen Escolano; Mercè Pallàs
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin.

Authors:  Martha G Welch; Thomas B Welch-Horan; Muhammad Anwar; Nargis Anwar; Robert J Ludwig; David A Ruggiero
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Imidazoleacetic acid-ribotide induces depression of synaptic responses in hippocampus through activation of imidazoline receptors.

Authors:  O Bozdagi; X B Wang; G P Martinelli; G Prell; V L Friedrich; G W Huntley; G R Holstein
Journal:  J Neurophysiol       Date:  2011-01-12       Impact factor: 2.714

4.  Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101.

Authors:  A Casanovas; G Olmos; J Ribera; M A Boronat; J E Esquerda; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 5.  Vestibulo-sympathetic responses.

Authors:  Bill J Yates; Philip S Bolton; Vaughan G Macefield
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

6.  Brain protection conferred by long-term administration of 2-(2-benzofuranyl)-2-imidazoline against experimental autoimmune encephalomyelitis.

Authors:  Ying-Biao Zhu; Nian-Ge Xia; Yuan-Tao Zhang; Xin-Shi Wang; Shan-Shan Liang; Wei-Yong Yin; Hui-Qin Xu; Sheng-Tao Hou; Rong-Yuan Zheng
Journal:  Neurochem Res       Date:  2014-12-19       Impact factor: 3.996

7.  Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors.

Authors:  P Sánchez-Blázquez; M A Boronat; G Olmos; J A García-Sevilla; J Garzón
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 8.  The role of the central nervous system in hypertension.

Authors:  J M Wyss; S H Carlson
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

Review 9.  Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence.

Authors:  Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2007-07-25       Impact factor: 5.046

10.  Presynaptic I1-imidazoline receptors reduce GABAergic synaptic transmission in striatal medium spiny neurons.

Authors:  Mitsuo Tanabe; Yurika Kino; Motoko Honda; Hideki Ono
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.